返回 Agenda
S10 : Impact of ICH E6 (R3) on GCP Inspection: from Global Perspectives
Session Chair(s)
Junko Sato, PhD
Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Speaker(s)
Kotaro Fukuda
Pharmaceuticals and Medical Devices Agency, Japan
Mitsuaki Aoyagi
Japan Pharmaceutical Manufacturers Association (JPMA), Japan
Yoshiaki Ohyama
Gunma University Hospital, Japan
Director, Professor, Innovative Medical Reserch Center
Yuka Kubota
Gunma University Hospital, Japan
Innovative Medical Research Center